Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone Neoplasms | 60 | 2024 | 2527 | 4.450 |
Why?
|
Sarcoma | 23 | 2023 | 1800 | 1.730 |
Why?
|
Chondrosarcoma | 10 | 2023 | 295 | 1.360 |
Why?
|
Osteosarcoma | 14 | 2022 | 896 | 1.190 |
Why?
|
Soft Tissue Neoplasms | 15 | 2023 | 1158 | 1.170 |
Why?
|
Bone Cements | 5 | 2021 | 325 | 1.130 |
Why?
|
Fractures, Spontaneous | 9 | 2024 | 231 | 1.110 |
Why?
|
Acetabulum | 6 | 2022 | 542 | 0.910 |
Why?
|
Arthroplasty, Replacement, Hip | 3 | 2023 | 1413 | 0.740 |
Why?
|
Chordoma | 7 | 2022 | 347 | 0.740 |
Why?
|
Humerus | 5 | 2021 | 272 | 0.710 |
Why?
|
Hip Prosthesis | 3 | 2023 | 921 | 0.700 |
Why?
|
Indocyanine Green | 1 | 2021 | 233 | 0.640 |
Why?
|
Bone Nails | 2 | 2021 | 220 | 0.640 |
Why?
|
Giant Cell Tumor of Bone | 2 | 2022 | 118 | 0.570 |
Why?
|
Bone Transplantation | 5 | 2018 | 927 | 0.520 |
Why?
|
General Practice | 2 | 2014 | 97 | 0.520 |
Why?
|
Negative-Pressure Wound Therapy | 3 | 2022 | 156 | 0.500 |
Why?
|
Pelvic Neoplasms | 3 | 2022 | 247 | 0.470 |
Why?
|
Reoperation | 10 | 2024 | 4304 | 0.450 |
Why?
|
Carcinoma | 2 | 2016 | 2328 | 0.450 |
Why?
|
Scapula | 3 | 2021 | 173 | 0.440 |
Why?
|
Orthopedic Procedures | 6 | 2020 | 1276 | 0.440 |
Why?
|
Fibrosarcoma | 3 | 2023 | 308 | 0.430 |
Why?
|
Spinal Neoplasms | 5 | 2022 | 703 | 0.410 |
Why?
|
Neoplasm Recurrence, Local | 15 | 2023 | 9278 | 0.400 |
Why?
|
Limb Salvage | 5 | 2021 | 480 | 0.400 |
Why?
|
Surgical Wound Infection | 5 | 2022 | 1530 | 0.380 |
Why?
|
Artificial Limbs | 3 | 2023 | 121 | 0.350 |
Why?
|
Fibromatosis, Aggressive | 3 | 2020 | 126 | 0.350 |
Why?
|
Retrospective Studies | 57 | 2024 | 80673 | 0.330 |
Why?
|
Leiomyosarcoma | 2 | 2023 | 422 | 0.320 |
Why?
|
Femur | 4 | 2021 | 1308 | 0.310 |
Why?
|
Orthopedics | 4 | 2022 | 898 | 0.290 |
Why?
|
Fractures, Bone | 3 | 2015 | 2045 | 0.280 |
Why?
|
Survival Rate | 18 | 2024 | 12727 | 0.270 |
Why?
|
Surgical Wound Dehiscence | 1 | 2007 | 212 | 0.260 |
Why?
|
Tumor Burden | 4 | 2018 | 1892 | 0.250 |
Why?
|
Clavicle | 2 | 2018 | 224 | 0.250 |
Why?
|
Hemipelvectomy | 2 | 2014 | 8 | 0.240 |
Why?
|
Femoral Neoplasms | 3 | 2016 | 84 | 0.240 |
Why?
|
Neoplasm Metastasis | 4 | 2021 | 4908 | 0.230 |
Why?
|
Middle Aged | 65 | 2024 | 220835 | 0.230 |
Why?
|
Humans | 119 | 2024 | 761098 | 0.230 |
Why?
|
Fracture Fixation, Internal | 3 | 2016 | 971 | 0.230 |
Why?
|
Sarcoma, Synovial | 3 | 2017 | 153 | 0.230 |
Why?
|
Postoperative Complications | 9 | 2020 | 15634 | 0.220 |
Why?
|
Extremities | 6 | 2023 | 867 | 0.220 |
Why?
|
Pelvic Bones | 2 | 2016 | 270 | 0.210 |
Why?
|
Bandages | 2 | 2021 | 269 | 0.210 |
Why?
|
Liposarcoma, Myxoid | 2 | 2021 | 60 | 0.210 |
Why?
|
Sacrum | 2 | 2022 | 275 | 0.210 |
Why?
|
Follow-Up Studies | 19 | 2024 | 39121 | 0.210 |
Why?
|
Prosthesis Design | 3 | 2023 | 2115 | 0.210 |
Why?
|
Adult | 58 | 2024 | 221083 | 0.200 |
Why?
|
Aged | 48 | 2024 | 169266 | 0.200 |
Why?
|
Granuloma, Giant Cell | 1 | 2021 | 32 | 0.200 |
Why?
|
Male | 74 | 2024 | 360675 | 0.190 |
Why?
|
Sarcoma, Alveolar Soft Part | 2 | 2016 | 43 | 0.190 |
Why?
|
Female | 77 | 2024 | 392458 | 0.190 |
Why?
|
Ecchymosis | 1 | 2021 | 32 | 0.190 |
Why?
|
Venous Thrombosis | 2 | 2023 | 1304 | 0.190 |
Why?
|
Giant Cells | 1 | 2021 | 188 | 0.190 |
Why?
|
Treatment Outcome | 29 | 2024 | 64670 | 0.190 |
Why?
|
Debridement | 1 | 2024 | 493 | 0.190 |
Why?
|
Prognosis | 19 | 2024 | 29672 | 0.180 |
Why?
|
Bone Cysts | 1 | 2021 | 48 | 0.180 |
Why?
|
Fibula | 2 | 2021 | 266 | 0.180 |
Why?
|
Chondroblastoma | 1 | 2020 | 47 | 0.180 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 204 | 0.180 |
Why?
|
Adult Children | 1 | 2021 | 103 | 0.180 |
Why?
|
Hip Dislocation | 1 | 2023 | 248 | 0.180 |
Why?
|
Prosthesis Failure | 2 | 2023 | 1204 | 0.180 |
Why?
|
Algorithms | 6 | 2023 | 14023 | 0.180 |
Why?
|
Muscle Neoplasms | 1 | 2021 | 130 | 0.170 |
Why?
|
Radiotherapy, Adjuvant | 7 | 2016 | 1784 | 0.170 |
Why?
|
Prostheses and Implants | 1 | 2007 | 1276 | 0.170 |
Why?
|
Neoplasms | 5 | 2023 | 22125 | 0.170 |
Why?
|
Tibia | 3 | 2023 | 1070 | 0.170 |
Why?
|
Quality of Life | 5 | 2021 | 13362 | 0.170 |
Why?
|
Lower Extremity | 4 | 2021 | 1201 | 0.170 |
Why?
|
RNA-Binding Protein EWS | 1 | 2021 | 210 | 0.170 |
Why?
|
Osteochondroma | 1 | 2019 | 44 | 0.170 |
Why?
|
Rhabdomyosarcoma | 1 | 2022 | 358 | 0.160 |
Why?
|
Osteotomy | 2 | 2018 | 836 | 0.160 |
Why?
|
Decision Support Techniques | 2 | 2020 | 2000 | 0.160 |
Why?
|
RANK Ligand | 1 | 2020 | 318 | 0.160 |
Why?
|
NFATC Transcription Factors | 1 | 2021 | 390 | 0.160 |
Why?
|
Adolescent | 33 | 2021 | 88271 | 0.160 |
Why?
|
Osteitis Deformans | 2 | 2015 | 54 | 0.160 |
Why?
|
Pulmonary Embolism | 3 | 2023 | 2571 | 0.150 |
Why?
|
Young Adult | 29 | 2021 | 59199 | 0.150 |
Why?
|
Spouses | 1 | 2021 | 284 | 0.150 |
Why?
|
Prosthesis-Related Infections | 1 | 2024 | 488 | 0.150 |
Why?
|
Combined Modality Therapy | 9 | 2021 | 8519 | 0.150 |
Why?
|
Fluorescence | 1 | 2021 | 754 | 0.150 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2018 | 70 | 0.150 |
Why?
|
Gene Fusion | 1 | 2021 | 355 | 0.150 |
Why?
|
Hypoalbuminemia | 1 | 2018 | 86 | 0.150 |
Why?
|
Metals | 1 | 2022 | 712 | 0.150 |
Why?
|
Hemophilia A | 1 | 2021 | 359 | 0.150 |
Why?
|
Bone Screws | 1 | 2021 | 531 | 0.150 |
Why?
|
Twins, Conjoined | 1 | 2017 | 41 | 0.150 |
Why?
|
Venous Thromboembolism | 2 | 2023 | 1868 | 0.150 |
Why?
|
Arthroplasty | 2 | 2017 | 310 | 0.150 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2019 | 170 | 0.150 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 77 | 0.140 |
Why?
|
Chondrosarcoma, Mesenchymal | 1 | 2016 | 12 | 0.140 |
Why?
|
Upper Extremity | 2 | 2020 | 658 | 0.140 |
Why?
|
Leg Bones | 1 | 2016 | 19 | 0.140 |
Why?
|
In Situ Hybridization | 1 | 2020 | 1900 | 0.140 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2019 | 549 | 0.140 |
Why?
|
Calcaneus | 2 | 2009 | 142 | 0.130 |
Why?
|
Bone Density Conservation Agents | 2 | 2014 | 795 | 0.130 |
Why?
|
Bioethical Issues | 1 | 2017 | 120 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 636 | 0.130 |
Why?
|
Aged, 80 and over | 19 | 2021 | 58946 | 0.130 |
Why?
|
Musculoskeletal Diseases | 1 | 2021 | 597 | 0.120 |
Why?
|
Neurofibromatosis 1 | 2 | 2019 | 561 | 0.120 |
Why?
|
Symphysiotomy | 1 | 2014 | 2 | 0.120 |
Why?
|
Photochemotherapy | 1 | 2021 | 826 | 0.120 |
Why?
|
Disaster Planning | 1 | 2021 | 557 | 0.120 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1723 | 0.120 |
Why?
|
Disasters | 1 | 2021 | 520 | 0.120 |
Why?
|
Hip | 1 | 2016 | 255 | 0.120 |
Why?
|
Survival Analysis | 7 | 2021 | 10083 | 0.120 |
Why?
|
Histiocytoma, Malignant Fibrous | 2 | 2014 | 55 | 0.120 |
Why?
|
Radiotherapy Dosage | 7 | 2021 | 2898 | 0.110 |
Why?
|
Transplantation, Homologous | 3 | 2009 | 4822 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2016 | 3512 | 0.110 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2018 | 710 | 0.110 |
Why?
|
Nomograms | 1 | 2015 | 230 | 0.110 |
Why?
|
SEER Program | 4 | 2021 | 1450 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 1420 | 0.110 |
Why?
|
Fibromatosis, Abdominal | 1 | 2012 | 21 | 0.100 |
Why?
|
Pain Measurement | 3 | 2021 | 3548 | 0.100 |
Why?
|
Myxosarcoma | 1 | 2012 | 11 | 0.100 |
Why?
|
Humeral Fractures | 1 | 2015 | 282 | 0.100 |
Why?
|
Femoral Fractures | 1 | 2016 | 375 | 0.100 |
Why?
|
Child | 21 | 2022 | 80134 | 0.100 |
Why?
|
Surgical Flaps | 2 | 2014 | 1670 | 0.100 |
Why?
|
Malnutrition | 1 | 2018 | 622 | 0.100 |
Why?
|
Pyrimidines | 2 | 2018 | 3026 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3634 | 0.100 |
Why?
|
Pelvis | 1 | 2016 | 734 | 0.090 |
Why?
|
Fracture Fixation | 1 | 2013 | 366 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2016 | 970 | 0.090 |
Why?
|
Awards and Prizes | 1 | 2015 | 362 | 0.090 |
Why?
|
Fibrous Dysplasia, Monostotic | 1 | 2010 | 8 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1745 | 0.090 |
Why?
|
Knee Joint | 1 | 2018 | 1677 | 0.080 |
Why?
|
Patient Selection | 3 | 2020 | 4245 | 0.080 |
Why?
|
Lymphoma | 1 | 2018 | 1898 | 0.080 |
Why?
|
Osteoporotic Fractures | 1 | 2014 | 410 | 0.080 |
Why?
|
Diphosphonates | 1 | 2014 | 636 | 0.080 |
Why?
|
Neoplasm Staging | 5 | 2013 | 11118 | 0.080 |
Why?
|
Cervical Vertebrae | 1 | 2015 | 976 | 0.080 |
Why?
|
Sarcoma, Clear Cell | 1 | 2009 | 72 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5494 | 0.080 |
Why?
|
beta Catenin | 1 | 2013 | 1039 | 0.080 |
Why?
|
Antineoplastic Agents | 5 | 2020 | 13630 | 0.080 |
Why?
|
Diagnosis, Differential | 4 | 2021 | 12975 | 0.070 |
Why?
|
Furans | 1 | 2009 | 201 | 0.070 |
Why?
|
Risk Factors | 11 | 2024 | 74219 | 0.070 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2010 | 258 | 0.070 |
Why?
|
Walking | 1 | 2015 | 1194 | 0.070 |
Why?
|
Staining and Labeling | 2 | 2022 | 1081 | 0.070 |
Why?
|
Morbidity | 1 | 2013 | 1750 | 0.070 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13382 | 0.070 |
Why?
|
Hypercalcemia | 2 | 2024 | 423 | 0.070 |
Why?
|
Biopsy, Needle | 2 | 2014 | 1624 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 2 | 2016 | 3163 | 0.070 |
Why?
|
Reproducibility of Results | 6 | 2021 | 20120 | 0.070 |
Why?
|
Mental Health | 1 | 2021 | 3251 | 0.070 |
Why?
|
Cohort Studies | 7 | 2022 | 41486 | 0.070 |
Why?
|
Vascular Neoplasms | 1 | 2008 | 166 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4572 | 0.070 |
Why?
|
Melanoma | 1 | 2024 | 5694 | 0.060 |
Why?
|
Tourniquets | 1 | 2006 | 107 | 0.060 |
Why?
|
Neoadjuvant Therapy | 3 | 2014 | 2827 | 0.060 |
Why?
|
Kidney Neoplasms | 2 | 2016 | 4251 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7405 | 0.060 |
Why?
|
Spinal Diseases | 1 | 2010 | 562 | 0.060 |
Why?
|
Photons | 1 | 2008 | 589 | 0.060 |
Why?
|
Fingers | 1 | 2008 | 506 | 0.060 |
Why?
|
Hemangiosarcoma | 1 | 2007 | 215 | 0.060 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2009 | 732 | 0.060 |
Why?
|
Time Factors | 7 | 2021 | 39953 | 0.060 |
Why?
|
Medical Oncology | 1 | 2015 | 2316 | 0.060 |
Why?
|
MicroRNAs | 1 | 2019 | 3758 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2024 | 6482 | 0.050 |
Why?
|
Surgical Procedures, Operative | 1 | 2015 | 1923 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2018 | 11732 | 0.050 |
Why?
|
Child, Preschool | 10 | 2021 | 42217 | 0.050 |
Why?
|
Graft Survival | 2 | 2018 | 3841 | 0.050 |
Why?
|
Hemangioma | 1 | 2008 | 727 | 0.050 |
Why?
|
Boston | 3 | 2020 | 9324 | 0.050 |
Why?
|
Joint Prosthesis | 1 | 2024 | 253 | 0.050 |
Why?
|
Protein Kinases | 1 | 2009 | 1607 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15845 | 0.050 |
Why?
|
Thrombin Time | 1 | 2021 | 7 | 0.050 |
Why?
|
Probability | 1 | 2007 | 2478 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 2 | 1997 | 841 | 0.050 |
Why?
|
Incidence | 3 | 2019 | 21357 | 0.050 |
Why?
|
Radiography, Interventional | 1 | 2008 | 1122 | 0.050 |
Why?
|
Depression | 1 | 2021 | 8130 | 0.050 |
Why?
|
Preoperative Care | 3 | 2021 | 2242 | 0.050 |
Why?
|
Range of Motion, Articular | 2 | 2018 | 1590 | 0.050 |
Why?
|
Cardiovascular Abnormalities | 1 | 2001 | 143 | 0.050 |
Why?
|
Cadaver | 1 | 2005 | 1358 | 0.040 |
Why?
|
Hand Deformities, Congenital | 1 | 2001 | 174 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2455 | 0.040 |
Why?
|
Bayes Theorem | 2 | 2018 | 2327 | 0.040 |
Why?
|
Shoulder Joint | 1 | 2007 | 742 | 0.040 |
Why?
|
Neoplasm, Residual | 3 | 2012 | 1008 | 0.040 |
Why?
|
Risk Assessment | 4 | 2020 | 24013 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12467 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5318 | 0.040 |
Why?
|
Postoperative Care | 2 | 2021 | 1469 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15308 | 0.040 |
Why?
|
Neurilemmoma | 1 | 2004 | 523 | 0.040 |
Why?
|
Brachytherapy | 2 | 2021 | 1223 | 0.040 |
Why?
|
Forearm | 1 | 2001 | 427 | 0.040 |
Why?
|
Factor VIII | 1 | 2021 | 349 | 0.040 |
Why?
|
Diphenylamine | 1 | 2018 | 49 | 0.040 |
Why?
|
Acromion | 1 | 2018 | 32 | 0.040 |
Why?
|
Foot | 1 | 2023 | 575 | 0.040 |
Why?
|
Bone Plates | 1 | 2022 | 465 | 0.040 |
Why?
|
Curettage | 1 | 2018 | 74 | 0.040 |
Why?
|
Relative Biological Effectiveness | 2 | 2011 | 311 | 0.040 |
Why?
|
Recovery of Function | 2 | 2020 | 2981 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2009 | 2067 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4947 | 0.040 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2002 | 303 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 2 | 2018 | 5662 | 0.040 |
Why?
|
Arm | 1 | 2021 | 589 | 0.040 |
Why?
|
Ethics Committees, Clinical | 1 | 2017 | 56 | 0.040 |
Why?
|
Wound Healing | 2 | 2007 | 2801 | 0.040 |
Why?
|
Logistic Models | 2 | 2023 | 13254 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2018 | 36418 | 0.040 |
Why?
|
Pyridines | 1 | 2009 | 2872 | 0.040 |
Why?
|
Edema | 1 | 2021 | 765 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2014 | 6817 | 0.030 |
Why?
|
Decision Trees | 1 | 2018 | 505 | 0.030 |
Why?
|
Radiotherapy, Conformal | 2 | 2011 | 548 | 0.030 |
Why?
|
Massachusetts | 2 | 2010 | 8836 | 0.030 |
Why?
|
Ear, External | 1 | 1997 | 165 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 5 | 2021 | 20600 | 0.030 |
Why?
|
Hand | 1 | 2001 | 902 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1329 | 0.030 |
Why?
|
Embolism, Fat | 1 | 2015 | 46 | 0.030 |
Why?
|
Shoulder | 1 | 2017 | 301 | 0.030 |
Why?
|
Serum Albumin | 1 | 2018 | 674 | 0.030 |
Why?
|
Prospective Studies | 5 | 2021 | 54419 | 0.030 |
Why?
|
Wounds, Penetrating | 1 | 1997 | 313 | 0.030 |
Why?
|
Operating Rooms | 1 | 2021 | 790 | 0.030 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 2016 | 159 | 0.030 |
Why?
|
United States | 5 | 2021 | 72337 | 0.030 |
Why?
|
Emergencies | 1 | 2021 | 1217 | 0.030 |
Why?
|
Mutation | 2 | 2022 | 30006 | 0.030 |
Why?
|
Ganglion Cysts | 1 | 2014 | 27 | 0.030 |
Why?
|
Graft Rejection | 1 | 2007 | 4479 | 0.030 |
Why?
|
Heparin | 1 | 2021 | 1632 | 0.030 |
Why?
|
Models, Anatomic | 1 | 2017 | 684 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26068 | 0.030 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 591 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2016 | 998 | 0.030 |
Why?
|
Bone Development | 1 | 1997 | 470 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2621 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2913 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1818 | 0.030 |
Why?
|
Granuloma, Plasma Cell | 1 | 2014 | 80 | 0.030 |
Why?
|
Myositis Ossificans | 1 | 2014 | 77 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2018 | 1073 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2017 | 1837 | 0.030 |
Why?
|
Catheter Ablation | 1 | 2006 | 2751 | 0.030 |
Why?
|
Benzamides | 1 | 2018 | 1370 | 0.030 |
Why?
|
Radiography | 3 | 2010 | 6975 | 0.030 |
Why?
|
Infant | 5 | 2017 | 36164 | 0.030 |
Why?
|
Osteolysis | 1 | 2014 | 275 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2017 | 786 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3604 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2413 | 0.020 |
Why?
|
Radiodermatitis | 1 | 2011 | 60 | 0.020 |
Why?
|
Bone and Bones | 1 | 2022 | 2567 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3307 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2022 | 11066 | 0.020 |
Why?
|
Doxorubicin | 2 | 2009 | 2224 | 0.020 |
Why?
|
Nutritional Status | 1 | 2018 | 1597 | 0.020 |
Why?
|
Comorbidity | 1 | 2005 | 10514 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 2017 | 1422 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3591 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1611 | 0.020 |
Why?
|
Spine | 1 | 2017 | 1128 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2009 | 6224 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2010 | 510 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22157 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 1997 | 1964 | 0.020 |
Why?
|
Organs at Risk | 1 | 2011 | 359 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2813 | 0.020 |
Why?
|
Hematoma | 1 | 2014 | 763 | 0.020 |
Why?
|
Sulfonamides | 1 | 2018 | 1977 | 0.020 |
Why?
|
Skin Neoplasms | 2 | 2024 | 5809 | 0.020 |
Why?
|
Apoptosis | 2 | 2018 | 9478 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7189 | 0.020 |
Why?
|
Health Status | 1 | 2021 | 4077 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4386 | 0.020 |
Why?
|
Joint Instability | 1 | 2014 | 801 | 0.020 |
Why?
|
Osteoma, Osteoid | 1 | 1988 | 90 | 0.020 |
Why?
|
Radiotherapy | 1 | 2014 | 1498 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2008 | 478 | 0.020 |
Why?
|
Databases, Factual | 1 | 2022 | 7969 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5781 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9614 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5070 | 0.020 |
Why?
|
Protons | 1 | 2011 | 1112 | 0.020 |
Why?
|
Mesna | 1 | 2005 | 62 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2331 | 0.020 |
Why?
|
Lipids | 1 | 1997 | 3330 | 0.020 |
Why?
|
Ankle Joint | 1 | 2009 | 446 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 677 | 0.020 |
Why?
|
Ifosfamide | 1 | 2005 | 232 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2009 | 20981 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8236 | 0.010 |
Why?
|
Hyperplasia | 1 | 2008 | 1150 | 0.010 |
Why?
|
Radiation Injuries | 1 | 2011 | 1191 | 0.010 |
Why?
|
Pneumonia | 1 | 2015 | 2142 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2643 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 2011 | 1051 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14393 | 0.010 |
Why?
|
Cisplatin | 1 | 2009 | 1651 | 0.010 |
Why?
|
Dacarbazine | 1 | 2005 | 559 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16947 | 0.010 |
Why?
|
Blotting, Western | 1 | 2009 | 5033 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6123 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12096 | 0.010 |
Why?
|
Nephrectomy | 1 | 2006 | 938 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2017 | 4673 | 0.010 |
Why?
|
Spinal Cord | 1 | 2008 | 1807 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12058 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2057 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6420 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2864 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3535 | 0.010 |
Why?
|
History, 19th Century | 1 | 2002 | 718 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2005 | 2219 | 0.010 |
Why?
|
Patient Care Team | 1 | 2010 | 2513 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12983 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2001 | 1498 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5249 | 0.010 |
Why?
|
Hyalin | 1 | 1997 | 34 | 0.010 |
Why?
|
Ear Cartilage | 1 | 1997 | 62 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1997 | 213 | 0.010 |
Why?
|
Freeze Drying | 1 | 1997 | 101 | 0.010 |
Why?
|
Protein Denaturation | 1 | 1997 | 241 | 0.010 |
Why?
|
Transplantation, Heterotopic | 1 | 1997 | 175 | 0.010 |
Why?
|
Bone Matrix | 1 | 1997 | 120 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 11103 | 0.010 |
Why?
|
Cause of Death | 1 | 2007 | 3688 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15717 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5145 | 0.010 |
Why?
|
Calcification, Physiologic | 1 | 1997 | 170 | 0.010 |
Why?
|
History, 21st Century | 1 | 2002 | 1566 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2008 | 4421 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18385 | 0.010 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 1997 | 343 | 0.010 |
Why?
|
Hypertrophy | 1 | 1997 | 558 | 0.010 |
Why?
|
Gelatin | 1 | 1997 | 221 | 0.010 |
Why?
|
Connective Tissue | 1 | 1997 | 419 | 0.010 |
Why?
|
Ossification, Heterotopic | 1 | 1997 | 235 | 0.010 |
Why?
|
Epidermis | 1 | 1997 | 526 | 0.010 |
Why?
|
History, 20th Century | 1 | 2002 | 2764 | 0.010 |
Why?
|
Mesoderm | 1 | 1997 | 673 | 0.010 |
Why?
|
Occupational Diseases | 1 | 2002 | 1490 | 0.010 |
Why?
|
Capillaries | 1 | 1997 | 755 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1997 | 857 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10421 | 0.010 |
Why?
|
Muscles | 1 | 1997 | 1567 | 0.010 |
Why?
|
Palliative Care | 1 | 2007 | 3593 | 0.010 |
Why?
|
Animals | 3 | 2018 | 168083 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2001 | 1419 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2012 | 9025 | 0.010 |
Why?
|
Rabbits | 1 | 1997 | 4749 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 26187 | 0.010 |
Why?
|
Cell Division | 1 | 1997 | 4451 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13506 | 0.010 |
Why?
|
Fatty Acids | 1 | 1997 | 1806 | 0.000 |
Why?
|
Pregnancy | 1 | 2010 | 29872 | 0.000 |
Why?
|
Monocytes | 1 | 1997 | 2570 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1997 | 6507 | 0.000 |
Why?
|
Stem Cells | 1 | 1997 | 3512 | 0.000 |
Why?
|
Skin | 1 | 1997 | 4473 | 0.000 |
Why?
|
Macrophages | 1 | 1997 | 5754 | 0.000 |
Why?
|
Rats | 1 | 1997 | 23713 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1997 | 9185 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1997 | 11505 | 0.000 |
Why?
|
Inflammation | 1 | 1997 | 10758 | 0.000 |
Why?
|
Signal Transduction | 1 | 1997 | 23415 | 0.000 |
Why?
|